Company will share data demonstrating CD47 overexpression as key predictive biomarker for response with the Company’s lead ...

Purple Biotech Ltd. has announced promising new data regarding its therapy NT219, a dual inhibitor targeting IRS1/2 and STAT3, for the treatment of head and neck squamous cell carcinoma (HNSCC) and ...

REHOVOT, Israel, March 16, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (PPBT), a clinical-stage company developing first-in-class, effective and durable therapies that harness the power of the tumor ...

“The integration of artificial intelligence (AI), biomarkers, ageing biology, and longevity medicine stands as a cornerstone for extending human healthy lifespan.” This paper summarizes recent ...

Patients with serum CEACAM1 within a defined range prior to treatment demonstrated increased overall survival (OS) and progression free survival (PFS) when treated with CM24 Definition of serum ...

Troculeucel, a cryopreserved autologous, non-genetically modified NK cell product, appears to cross the blood brain barrier (BBB) via CXCR3, to reduce neuroinflammation via a simple IV administration.

78% reduction in risk of death and 81% reduction in risk of progression or death in defined pretreatment ranges of serum or tumor CEACAM1 subgroup 61% reduction is risk of death and 72% reduction in ...

FDA recommends that IO Biotech not submit a Biologics License Application (BLA) based on the data from the IOB-013 clinical trial Company plans to design new registrational study for Cylembio for the ...

Rockcliffe Labs Inc. (“Rockcliffe Labs” or the “Company”), a Canadian biotechnology venture creation platform, announces the ...

Company will share data demonstrating CD47 overexpression as key predictive biomarker for response with the Company’s lead candidate, evorpacept, ...

“The integration of artificial intelligence (AI), biomarkers, ageing biology, and longevity medicine stands as a cornerstone for extending human healthy lifespan” “The integration of artificial ...